About Bio-Gate AG
Bio-Gate AG is technology health company and is one of the world's leading providers of innovative technologies and individual solutions for health and hygiene, which can make living together safer, more carefree and healthier and improve the well-being of every individual. Bio-Gate specializes in providing materials and surfaces with antiviral and antimicrobial properties. Bio-Gate AG refines materials and products, especially in the field of medical technology, such as the coating of implants or wound dressings. In addition, Bio-Gate technologies are used to uniquely enhance topical wound care products, skincare and cosmetics, consumer and industrial products such as paints and varnishes and antimicrobial plastics.
This publication constitutes neither an offer to sell nor an invitation to buy securities. The shares in Bio-Gate AG (the "Shares") may not be offered or sold in the United States or to or for the account or benefit of "U.S. persons" (as such term is defined in Regulation S under the U.S. Securities Act of 1933, as amended (the "Securities Act")). The securities have already been sold.
/ins Protective Film Spray from Bio-Gate used for the first time in public transport in Nuremberg Advanced negotiations with further potential customers Successful commercialization for use in schools, public transport, banks and fitness studios
HyProtect TM - Focus on the antimicrobial coating of revision implants for knee and hip care in human medicine Aesculap can start the regulatory approval process for certain implants Broad international scope of cooperation
/ins Tested products are already available on the market Additional new products with antiviral effects soon to be launched Bio-Gate products suitable for extending existing hygiene strategies
/ins Nuremberg, 29 January 2019 – Bio-Gate AG, concluded a pre-submission with FDA regarding its HyProtect™ coating technology, which is an ultrathin plasma coating containing pure silver and polysiloxane that protects the surfaces of medical implants against bacterial colonization.
/INS. Nürnberg, (Feb. 2, 2015) – Bio-Gate AG, Germany announces today that it has signed a license agreement with VetBiotek for marketing and selling products in the veterinary channel that feature Bio-Gate’s MicroSilver BG™ technology, a pure silver powder consisting of highly porous and micro-sized particles of medical-grade silver. The products distributed by VetBiotek will be used for dermatological applications associated with companion animals. The patent rights granted to VetBiotek are exclusive for the United States and Canada and non-exclusive elsewhere.